This federal contract award is for the delivery of the pharmaceutical product Dupixent (300 mg/2 ml pen, 2 ml) to the Defense Logistics Agency (DLA). The fixed-price delivery order contract is valued at $11,130.10 and has an ultimate completion date of January 2, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award did not have a set-aside designation, indicating open competition.
Generated 4/1/25, 10:46 AM